Cancer Vaccine Market Anticipates Robust Growth with a Projected 8.87% CAGR Through 2028

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to's offering.

The Global Cancer Vaccine Market has seen momentous growth, with the latest industry analysis projecting a notable surge in market value from USD 7.55 billion in 2022 to an expected USD 12.46 billion by 2028. This significant rise reflects a compound annual growth rate (CAGR) of 8.87% during the forecast period.

Cancer vaccines play a crucial role in the future of oncological treatments, utilizing the body's innate immunity to target and eradicate cancerous cells. The burgeoning market is driven by the soaring demand for preventive vaccines and advancements in vaccine technology, alongside the revolutionary breakthroughs in immunotherapy.

Key Drivers Shaping the Market Landscape

Growth in Preventive Vaccines Sector:
Preventive vaccines, such as those targeting Human Papillomavirus (HPV) and Hepatitis B, have significantly reduced the incidence of related cancers, contributing to the expansion of the market.

Technological Innovations in Vaccine Development: Recent advancements, such as recombinant vaccines and viral vector and DNA cancer vaccines, are charting new territory in cancer care by enhancing personalized treatment effectiveness.

Robust Demand for Immune Checkpoint Inhibitors: A breakthrough in cancer treatment, immune checkpoint inhibitors have transformed oncological therapeutics, propelling the market forward.

Emerging Challenges and Regional Market Insights

The complexity of cancer immunology presents significant challenges, with the need for an in-depth understanding of the cancer-immune system interplay being of utmost importance. Moreover, the intricacies involved in identifying appropriate vaccine targets persist as a challenge.

In the regional context, North America has taken the forefront in the Cancer Vaccines Market, holding the largest market share due to an increasing prevalence of cancer, significant investments in healthcare infrastructure, and concentrated efforts in research and development.

Collaborative Efforts and Segmental Growth Fostering Market Trends

Strategic collaborations and partnerships across various sectors within the healthcare industry have become integral in pushing the boundaries of cancer vaccine research and facilitating the sharing of resources and knowledge.

Vaccine type insights reveal that preventive vaccines continue to dominate the market, while cervical cancer leads in the indication type segment. The recombinant vaccine segment also commands a significant portion of the market share due to the reliance of major industry players on this technology.

The Global Cancer Vaccine Market report delivers a comprehensive analysis of market dynamics, segmentation, regional insights, and the competitive landscape. With the commitment towards understanding intricate market trends and enhancing the understanding of strategies pivotal to market growth, this report is a testament to the relentless pursuit of innovation in the fight against cancer.

Market Players Leading the Charge

  • Merck & Co., Inc.
  • GSK plc
  • Dendreon Pharmaceuticals LLC.
  • Dynavax Technologies.
  • Amgen, Inc.
  • Moderna, Inc.
  • Sanofi SA
  • AstraZeneca Pharmaceuticals LP
  • Bristol-Myers Squibb Company

This analysis aims to empower stakeholders, investors, and professionals in the healthcare sector with the strategic insights needed to navigate the evolving landscape of the Global Cancer Vaccine Market.

Key Attributes:

Report AttributeDetails
No. of Pages170
Forecast Period2023 - 2028
Estimated Market Value (USD) in 2023$7.55 Billion
Forecasted Market Value (USD) by 2028$12.46 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Cancer Vaccine Market

Contact Data